Enzyme replacement therapy in Fabry cardiomyopathy: an incomplete treatment

被引：0
|
作者：
Nicholls, Kathleen [1 ,2 ]
机构：
[1] Royal Melbourne Hosp, Nephrol, Parkville, Vic, Australia
[2] Univ Melbourne Med, Royal Melbourne Hosp, Parkville, Vic, Australia
来源：
HEART | 2024年 / 110卷 / 15期
关键词：
genetic diseases; inborn; metabolic diseases; cardiomyopathy; restrictive; CARDIAC INVOLVEMENT; AGALSIDASE-BETA; DISEASE;
D O I：
10.1136/heartjnl-2024-324238
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：971 / 971
页数：1
相关论文
共 50 条
  • [31] Withdrawal of enzyme replacement therapy in Fabry disease: Indirect evidence of treatment benefit?
    West, M.
    Lemoine, K.
    CLINICAL THERAPEUTICS, 2007, 29 : S32 - S33
  • [32] Withdrawal of enzyme replacement therapy in Fabry disease: Indirect evidence of treatment benefit?
    West, Michael
    LeMoine, Kaye
    MOLECULAR GENETICS AND METABOLISM, 2007, 92 (04) : S32 - S32
  • [33] Long-term evolution of Fabry cardiomyopathy under enzyme replacement therapy in the Swiss Fabry cohort. An echocardiographic study
    Monney, P.
    Namdar, M.
    Schmied, C.
    Gruner, C.
    Dormond, O.
    Krayenbuhl, P. A.
    Barbey, F.
    Nowak, A.
    EUROPEAN HEART JOURNAL, 2019, 40 : 497 - 497
  • [34] Late gadolinium enhancement image masquerading as hypertrophic cardiomyopathy in Fabry disease receiving enzyme replacement therapy
    Yano, Toshiyuki
    Oshima, Hiroto
    Miki, Takayuki
    Tanaka, Marenao
    Muranaka, Atsuko
    Osanami, Arata
    Takahashi, Fumihiko
    Miura, Tetsuji
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 203 : 136 - 137
  • [35] Evaluating Enzyme Replacement Therapy in Fabry Disease Reply
    Blum, Arnon
    Podovitzky, Oxana
    Nuri, Julia
    Khasin, Moshe
    ARCHIVES OF INTERNAL MEDICINE, 2010, 170 (06) : 574 - 574
  • [36] Anderson-Fabry disease:: Enzyme replacement therapy
    Leon-Mateos, A
    Fernández-Redondo, V
    Beiras, A
    Toribio, J
    ACTA DERMATO-VENEREOLOGICA, 2004, 84 (01) : 88 - 89
  • [37] Enzyme replacement therapy in nine patients with Fabry disease
    Alamartine, É
    M S-MEDECINE SCIENCES, 2005, 21 : 62 - 65
  • [38] Effect of enzyme replacement therapy on fabry nephropathy progression
    Nowak, Albina
    Koch, Gilbert
    Huynh-Do, Uyen
    Siegenthaler, Martin
    Marti, Hans-Peter
    Battegay, Edouard
    Pfister, Marc
    SWISS MEDICAL WEEKLY, 2015, 145 : 16S - 17S
  • [39] Enzyme replacement therapy for Anderson-Fabry disease
    El Dib, Regina P.
    Nascimento, Paulo
    Pastores, Gregory M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (02):
  • [40] EFFECTS OF INTERRUPTION OF ENZYME REPLACEMENT THERAPY IN FABRY DISEASE
    Netto, C. B. O.
    Vieira, T.
    Jardim, L.
    Burin, M.
    Matte, U.
    Pereira, F.
    Souza, C.
    Schwartz, I.
    Giugliani, R.
    MOLECULAR GENETICS AND METABOLISM, 2009, 98 (1-2) : 74 - 74
12345